[Delayed allergic reaction to Chlorambucil (Leukeran). Case report and literature review].

Schweiz Med Wochenschr

Allergiestation der Dermatologischen Klinik und Poliklinik, Universitätsspital Zürich.

Published: October 1995

A 63-year-old man developed a mild hemorrhagic diathesis which led to the diagnosis of chronic lymphatic leukemia. Treatment with prednisone and chlorambucil was initiated. During the first 10 day-cycle (10 mg chlorambucil and 100 mg prednisone) no side effects were noted. On the 8th day of second cycle (10 mg chlorambucil and 25 mg prednisone) the patient noticed fever, tiredness, myalgia, pruritus and erythema on the skin. The third cycle (10 mg chlorambucil alone) hat to be stopped on the second day due to the development of myalgia, generalized erythroderma with exfoliation and edema of the face and arms. In the patch-test with chlorambucil, a strongly positive (histologically verified) allergic reaction was noted. A lymphocyte stimulation test (detecting in vitro lymphocytes sensitized to chlorambucil) was also positive. These findings, together with the marked clinical reaction to chlorambucil alone, led to the diagnosis of a delayed hypersensitivity reaction to chlorambucil. Such well documented allergic reactions to chlorambucil are very rarely described in the literature. Up to now only 1 case of immune hemolytic anemia, 1 case of Lyell-syndrome, 2 cases of delayed hypersensitivity reactions and a few cases of less well documented type I reactions have been described. In all these cases no crossreactivity with other alkylating agents occurred, and hence all patients could be successfully treated with cyclophosphamide.

Download full-text PDF

Source

Publication Analysis

Top Keywords

reaction chlorambucil
12
chlorambucil
10
allergic reaction
8
led diagnosis
8
cycle chlorambucil
8
chlorambucil positive
8
delayed hypersensitivity
8
well documented
8
[delayed allergic
4
reaction
4

Similar Publications

Background: About 80% of children with steroid-sensitive nephrotic syndrome (SSNS) have relapses. Of these children, half will relapse frequently, and are at risk of adverse effects from corticosteroids. While non-corticosteroid immunosuppressive medications prolong periods of remission, they have significant potential adverse effects.

View Article and Find Full Text PDF

Photoresponsive prodrug-based liposomes for controllable release of the anticancer drug chlorambucil.

J Mater Chem B

December 2024

Shanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry & Molecular Engineering, East China University of Science & Technology, 130# Meilong Road, Shanghai 200237, China.

The on-demand delivery and release of chemotherapeutic drugs have attracted great attention, among which photoresponsive prodrug systems have shown specific advantages for effective cancer treatment due to their spatiotemporal control, non-invasive nature and easy operation. Unlike the traditional strategy of physical encapsulation of drugs in liposomes, we herein report a biomimetic and photoresponsive drug delivery system (DDS) based on a lipid prodrug liposomal formulation (LNC), which combines the features of the prodrug and nanomedicines, and can realize photocontrollable release of anticancer drugs. The lipid prodrug comprises three functional moieties: a single-arm phospholipid (Lyso PC), an -nitrobenzyl alcohol (NB) and chlorambucil (CBL).

View Article and Find Full Text PDF

Enhanced DNA damage and anti-proliferative activity of a novel ruthenium complex with a chlorambucil-decorated ligand.

J Inorg Biochem

November 2024

University of Pisa, Department of Chemistry, and Industrial Chemistry, Via G. Moruzzi 13, I-56124 Pisa, Italy. Electronic address:

Triphenylphosphine substitution reactions of [RuCl(PPh)(tpm)]Cl, 1, featuring tris(pyrazolyl)methane (tpm) as ligand, with the chlorambucil-decorated pyridine ligand Py, 3-aminopyridine (Py) and 4-pyridinemethanol (Py) afforded the corresponding pyridine complexes 2-4 in high yields. Py was preliminarily obtained via esterification of 4-pyridinemethanol with chlorambucil. The new compounds Py and 2-3 were characterized by IR and multinuclear NMR spectroscopy.

View Article and Find Full Text PDF

Chlorambucil (CML) cures chronic lymphatic leukemia (white blood cell cancer). A high dose of CML can cause several side effects like bone marrow suppression, anemia, peripheral neuropathy, and infertility in the human body. In this research, we have synthesized a nanocomposite based on copper-doped titanium dioxide (CuTiO) adorned with 2D hexagonal boron nitride (CuTiO@BN) for the efficient electrochemical detection of CML.

View Article and Find Full Text PDF

The delivery of drugs to the brain in the therapy of diseases of the central nervous system (CNS) remains a continuing challenge because of the lack of delivery systems that can cross the blood-brain barrier (BBB). Therefore, there is a need to develop an innovative delivery method for the treatment of CNS diseases. Thus, we have investigated the interaction of γ-aminobutyric acid (GABA) and S-(-)-γ-amino-α-hydroxybutyric acid (GAHBA) with the GABA receptor by performing a docking study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!